Acadian Asset Management
AUGX

Acadian Asset Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Acadian Asset Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,381
Closed -$48K – 1857
2023
Q3 		$48K Buy
+9,381
New +$44K ﹤0.01% 1436

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Acadian Asset Management's AUGX Position: Q4 2023 in Review

Acadian Asset Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2023, closing a stake of 9,381 shares — an estimated $48K sold.

Acadian Asset Management first reported a position in AUGX in Q3 2023 and held it in 1 quarter. The position peaked at $48K in Q3 2023. 85 funds tracked by Wall St. Rank hold AUGX as of Q4 2023.

  • Acadian Asset Management reported no remaining Augmedix, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Acadian Asset Management sold 9,381 Augmedix, Inc. Common Stock shares in Q4 2023, an estimated $48K.
  • Acadian Asset Management first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Acadian Asset Management's Augmedix, Inc. Common Stock position peaked at $48K in Q3 2023.
  • 85 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2023.

Based on Acadian Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.